scholarly article | Q13442814 |
P50 | author | Carlos Blanco | Q56089029 |
Benjamin I Goldstein | Q88048305 | ||
P2093 | author name string | Shang-Min Liu | |
Regina Sala | |||
Carmen Morcillo | |||
Mariela Castellanos | |||
P2860 | cites work | Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions | Q22241102 |
Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication | Q22253024 | ||
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders | Q22305681 | ||
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey | Q28258215 | ||
The social readjustment rating scale | Q28259033 | ||
Depressive comorbidity of panic, social phobic, and obsessive–compulsive disorders re-examined: is there a bipolar ii connection? | Q30047804 | ||
Neuroimaging Studies of Amygdala Function in Anxiety Disorders | Q30790141 | ||
Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). | Q30925648 | ||
Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). | Q30977443 | ||
Bipolar disorder and panic disorder in families: an analysis of chromosome 18 data. | Q32061631 | ||
Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative | Q34026000 | ||
Clinical, demographic, and familial correlates of bipolar spectrum disorders among offspring of parents with bipolar disorder | Q34034010 | ||
The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues | Q34116326 | ||
Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder | Q34282011 | ||
Comorbid anxiety in children and adolescents with bipolar spectrum disorders: prevalence and clinical correlates | Q34300035 | ||
Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions | Q34338064 | ||
Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders | Q34393749 | ||
Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions | Q34456401 | ||
A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year | Q34531152 | ||
Development of lifetime comorbidity in the World Health Organization world mental health surveys | Q34674133 | ||
The epidemiology of chronic major depressive disorder and dysthymic disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions | Q35458096 | ||
Antidepressants in bipolar disorder: the case for caution | Q35592492 | ||
Homotypic versus heterotypic continuity of anxiety symptoms in young adolescents: evidence for distinctions between DSM-IV subtypes | Q35884304 | ||
The impact of bipolar depression. | Q36204430 | ||
Prevalence and correlates of bipolar I disorder among adults with primary youth-onset anxiety disorders | Q36392794 | ||
Anxiety and outcome in bipolar disorder | Q36551024 | ||
Gender differences in generalized anxiety disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). | Q36612447 | ||
Factors associated with the persistence and onset of new anxiety disorders in youth with bipolar spectrum disorders | Q36694036 | ||
Lifetime psychiatric disorders in school-aged offspring of parents with bipolar disorder: the Pittsburgh Bipolar Offspring study | Q37374207 | ||
Epidemiology and management of anxiety in patients with bipolar disorder | Q37618782 | ||
Treating nonspecific anxiety and anxiety disorders in patients with bipolar disorder: a review | Q37826247 | ||
The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder | Q39344604 | ||
Prevalence and development of psychiatric disorders in childhood and adolescence | Q39605940 | ||
Anxiety as a correlate of response to the acute treatment of bipolar I disorder | Q43544024 | ||
Bipolar-panic disorder comorbidity within bipolar disorder families: a study of siblings | Q43595763 | ||
Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder | Q43924840 | ||
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder | Q43947453 | ||
Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. | Q44418403 | ||
The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample | Q44487795 | ||
A prospective latent analyses study of psychiatric comorbidity of DSM-IV bipolar I and II disorders | Q44783566 | ||
Toward a comprehensive developmental model for major depression in women | Q44888657 | ||
Toward a comprehensive developmental model for major depression in men. | Q44916290 | ||
Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the national epidemiologic survey on alcohol and related conditions | Q45123969 | ||
Obsessive-compulsive syndromes and disorders: significance of comorbidity with bipolar and anxiety syndromes | Q45265662 | ||
Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study | Q45287914 | ||
Anxiety disorder comobidity in Bipolar I Disorder: relationship to depression severity and treatment outcome | Q46399770 | ||
Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder | Q46472998 | ||
The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder | Q46805387 | ||
Subsyndromal symptoms assessed in longitudinal, prospective follow‐up of a cohort of patients with bipolar disorder | Q47587920 | ||
Awareness of illness in patients with bipolar I disorder with or without comorbid anxiety disorders | Q47869437 | ||
The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey. | Q48777454 | ||
Clinical and research implications of panic-bipolar comorbidity in children and adolescents. | Q50895776 | ||
Anxious and non-anxious bipolar disorder. | Q51140340 | ||
Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression. | Q51949768 | ||
Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. | Q53237504 | ||
The epidemiology of DSM-III-R bipolar I disorder in a general population survey. | Q53357821 | ||
Bipolar–panic comorbidity in the general population: prevalence and associated morbidity | Q59480879 | ||
Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia | Q60633583 | ||
Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area Survey | Q72492878 | ||
Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry | Q73634869 | ||
Multiple anxiety disorder comorbidity in patients with mood spectrum disorders with psychotic features | Q74611788 | ||
Parsing the comorbidity between bipolar disorder and anxiety disorders: a familial risk analysis | Q74632712 | ||
The emerging epidemiology of hypomania and bipolar II disorder | Q77700788 | ||
Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder | Q80478861 | ||
Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes | Q80581807 | ||
P433 | issue | 7 | |
P921 | main subject | bipolar disorder | Q131755 |
P304 | page(s) | 865-872 | |
P577 | publication date | 2012-04-24 | |
P1433 | published in | Journal of Psychiatric Research | Q6295810 |
P1476 | title | Course of comorbid anxiety disorders among adults with bipolar disorder in the U.S. population | |
P478 | volume | 46 |
Q38547352 | A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: Part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. |
Q47731766 | Abnormal sleep duration associated with hastened depressive recurrence in bipolar disorder. |
Q37179788 | Anxiety comorbidity in bipolar spectrum disorders: the mediational role of perfectionism in prospective depressive symptoms |
Q47592105 | Are comorbid anxiety disorders a risk factor for suicide attempts in patients with mood disorders? A two-year prospective study |
Q27009995 | Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders |
Q45954620 | Clinical characterization of Italian suicide attempters with bipolar disorder. |
Q38194541 | Co-occurrence of anxiety and bipolar disorders: clinical and therapeutic overview |
Q60921185 | Comorbidity of bipolar and anxiety disorders: An overview of trends in research |
Q38415843 | Effects of comorbid anxiety disorders on the course of bipolar disorder-I. |
Q37424330 | Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder |
Q37502206 | Hypomania spectrum disorder in adolescence: a 15-year follow-up of non-mood morbidity in adulthood |
Q38805394 | Impact of irritability: a 2-year observational study of outpatients with bipolar I or schizoaffective disorder |
Q36381348 | Integrating bipolar disorder management in primary care |
Q48445218 | Interaction of DRD2TaqI, COMT, and ALDH2 genes associated with bipolar II disorder comorbid with anxiety disorders in Han Chinese in Taiwan |
Q47245996 | Irritable temperament and lifetime psychotic symptoms as predictors of anxiety symptoms in bipolar disorder |
Q38561962 | Lifetime prevalence of anxiety disorders in people with bipolar disorder: a systematic review and meta-analysis |
Q40073695 | Mixed state and suicide: Is the effect of mixed state on suicidal behavior more than the sum of its parts? |
Q47655611 | Positive and Negative Affect as Links Between Social Anxiety and Depression: Predicting Concurrent and Prospective Mood Symptoms in Unipolar and Bipolar Mood Disorders |
Q30571258 | Posttraumatic stress disorder, depression, and health-related quality of life in patients with bipolar disorder: review and new data from a multi-site community clinic sample |
Q60629721 | Predictors of longitudinal psychosocial functioning in bipolar youth transitioning to adults |
Q47848081 | Prevalence of current anxiety disorders in people with bipolar disorder during euthymia: a meta-analysis |
Q36682087 | Probability and predictors of treatment-seeking for substance use disorders in the U.S. |
Q42666942 | Specific anxiety disorders and subsequent risk for bipolar disorder: a nationwide study. |
Q39181704 | Suicide in bipolar disorder: characteristics and subgroups |
Q58429429 | The feasibility and acceptability of a novel anxiety in bipolar disorder intervention compared to treatment as usual: A randomized controlled trial |
Q52589635 | The role of lifetime anxiety history in the course of bipolar spectrum disorders. |
Q58567943 | Treatment of anxiety disorders in patients with comorbid bipolar disorder |
Q26798229 | Treatment-refractory anxiety; definition, risk factors, and treatment challenges |
Search more.